MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, in Advanced NSCLC ...

The movement of waves, patterns that carry sound, light or heat, through materials has been widely studied by physicists, as ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

A U.S. specialty biopharmaceutical company focused on dermatology, with operations centered on commercialization and ...

With mandatory labelling in the UK on hold, many are waiting for the EU to publish its proposal for recycling labelling under ...

IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab ...

This paper represents a valuable contribution to our understanding of how LFP oscillations and beta band coordination between the hippocampus and prefrontal cortex of rats may relate to learning.

Researchers have used multivalent amidinium ligands to boost perovskite solar cell efficiency to 25.4%, achieving over 95% ...

Moderna now anticipates ending 2025 with cash and cash equivalents worth $8.1 billion, up from its previous forecast of ...

Currently, Kyocera’s technology enables aerial images whose focal positions vary by wavelength. In the future, increasing the ...

Welcome, everyone, to the JPMorgan Healthcare Conference. We are pleased to have with us the Almirall management team here with us today, Carlos Gallardo, Chairman and CEO; Karl Ziegelbauer, CFO; Jon ...

The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.